Olanzapine induced hair loss in an adolescent case

S. Uygun
{"title":"Olanzapine induced hair loss in an adolescent case","authors":"S. Uygun","doi":"10.5455/pbs.20190519123229","DOIUrl":null,"url":null,"abstract":"Drug induced alopecia is a reversible side effect of psychopharmacological treatments. Diffuse hair loss occurs with use of antipsychotics more rarely than mood stabilizers shown to be related to alopecia. In the literature, there is only one case report presenting an atypical antipsychotic “quetiapine” induced hair loss during adolescence when individuals are more sensitive to undesirable effects of drugs. Olanzapine, a safe and well tolerated atypical antipsychotic, is prescribed in child and adolescent psychiatry clinics. Alopecia may not be described by children and adolescents, but clinicians should be aware of this problem that may lead to impair compliance with treatment. In the report, an adolescent case of alopecia related to use of olanzapine that recovered after cessation of the drug is presented.","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"51 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedPress psychiatry and behavioral sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/pbs.20190519123229","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Drug induced alopecia is a reversible side effect of psychopharmacological treatments. Diffuse hair loss occurs with use of antipsychotics more rarely than mood stabilizers shown to be related to alopecia. In the literature, there is only one case report presenting an atypical antipsychotic “quetiapine” induced hair loss during adolescence when individuals are more sensitive to undesirable effects of drugs. Olanzapine, a safe and well tolerated atypical antipsychotic, is prescribed in child and adolescent psychiatry clinics. Alopecia may not be described by children and adolescents, but clinicians should be aware of this problem that may lead to impair compliance with treatment. In the report, an adolescent case of alopecia related to use of olanzapine that recovered after cessation of the drug is presented.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
奥氮平导致青少年脱发的案例
药物性脱发是心理药物治疗的可逆副作用。与情绪稳定剂相比,使用抗精神病药物更少发生弥漫性脱发,这与脱发有关。在文献中,只有一个病例报告显示非典型抗精神病药物“奎硫平”在青少年时期引起脱发,而此时个体对药物的不良影响更敏感。奥氮平是一种安全且耐受性良好的非典型抗精神病药物,在儿童和青少年精神病学诊所开处方。儿童和青少年可能无法描述脱发,但临床医生应该意识到这一问题可能导致损害治疗依从性。在报告中,一个青少年脱发病例与使用奥氮平有关,停药后恢复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Measuring Disgust Proneness Using the Disgust Propensity and Sensitivity Scale-Revised: Psychometric Properties with Factorial Invariance in Obsessive Compulsive Disorder and Non-Clinical Samples Relationship Between Perceptions of COVID-19 and Social Media Use: A Cross-Sectional Study in Turkey The Development of a Scale to Measure Children’s Fear of Nursing Interventions and Instruments Used in Hospital The Effects of Child and Adolescent Attention Deficit / Hyperactivity Disorder and Associated Executive Function Deficits on Family Functioning The Relationship between Functioning Levels and Exercise Addiction, Personality, and Temperament Characteristics in Patients with Bipolar Disorder during Remission Period
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1